Biden Administration Announces Expansion of Medicare and Medicaid to Include Weight Loss Drugs Like Ozempic and Wegovy

Updated

The Biden-Harris administration proposed an expansion of Medicare and Medicaid coverage to include anti-obesity medications like Ozempic and Wegovy. The HighWire has reported about harms associated with the diabetes drug Ozempic, which has frequently been prescribed off-label for weight loss. Novo Nordisk, the manufacturer, also has a GLP-1 inhibitor made specifically for weight loss called Wegovy.

A September report described a 640% increase in overdose calls to the Utah poison control center for GLP-1 inhibitors, including Ozempic and Wegovy. Model Lottie Moss urged her podcast listeners to avoid taking the drug after she had serious side effects. Moss received the medication from a friend rather than a doctor and took double the recommended dose. After that, she could not keep water or food down. She also experienced a seizure and said taking the drug was the “worst decision” she had ever made.

Other severe side effects include stomach paralysis, gastrointestinal issues, gall bladder issues, pancreatitis, and suicidal ideation. These lasting side effects have been the basis for a wave of lawsuits against the Danish pharmaceutical company. Eli Lilly is another company that offers weight loss and diabetes drugs similar to Ozempic. Mounjaro is a diabetes drug but is also prescribed off-label for weight loss.

NIH data from 2017-2018 shows that 42.4% of American adults are obese, while a total of 73.1% are overweight or obese. Among children and adolescents aged 2-19, 19.3% are obese and another 16.1% are overweight. 35.4% of all children, including two-year-olds, are overweight or obese.

In the American market, Ozempic and other semaglutide GLP-1 inhibitors cost about $1,000 per month for a prescription, even though it costs the manufacturer only $5 to produce. Some estimates have said the cost will be closer to $1,600 per monthly dose. The Bureau of Labor Statistics report found that the average grocery bill per month is $556.76 in Hawaii for one person. The average for the country is between $238.46 and $434.33.

Fitness expert Jillian Michaels appeared on Fox News with Sean Hannity to discuss the use of semaglutide GLP-1 inhibitors for overweight and obese Americans. She said, “Wouldn’t it be more advantageous for the taxpaying American to take those dollars and give each and every one of those people three organic meals a day and a gym membership, counseling, fitness training, which with that kind of money, you can actually afford? So who is this really benefiting, Americans or the drug companies?”

Hannity pushed back lightly and asked about individuals who don’t have the willpower to eat healthy and exercise. Michaels described the factors that make eating healthy an issue of willpower and suggested a fundamental change regarding the way society consumes and shops for food.

“The reason people don’t have the discipline is because of our environment,” Michaels said. “Our environment is engineered to addict people to these ultra-processed foods and surround us with them. They’re ubiquitous; they’re everywhere. The idea here is not to force people to have superhuman willpower but to clean up the environment so they can function normally and not be addicted to these extremely toxic foods. The American people need help. And that’s what people like RFK are trying to do. They’re trying to give people the support they need in the most advantageous way possible.”

Robert F. Kennedy Jr. agrees with Michaels that the solution is providing healthy meals and encouraging exercise rather than putting overweight Americans on a new pharmaceutical drug. Kennedy said on Fox News with Greg Gutfeld that giving these medications to all overweight and obese Americans would cost $3 trillion a year. “If we spend about one-fifth of that giving good food, three meals a day, to every man, woman, and child in our country, we could solve the obesity and diabetes epidemic overnight for a tiny fraction of the cost. It’s the biggest company in Europe, but they’re not marketing it in Europe. They make this drug in Denmark, but in Denmark, they do not recommend it for diabetes or for obesity; they recommend dietary and behavioral changes.”

Kennedy was named as the next HHS Director by President-elect Trump and has shared that he opposes the use of semaglutide GLP-1 inhibitors for Americans who are overweight or obese. Dr. Mehmet Oz, a famous TV personality, was named the Administrator of the Centers for Medicare and Medicaid Services (CMS) for the incoming administration. Dr. Oz has promoted and spoken positively about this class of weight loss drugs. As HHS Director, Kennedy will oversee several agencies, including CMS.

Michaels said there is a “continuum of illness” and referred to severe cases in which this medication might be beneficial to certain candidates. However, she cautioned that the intent is to suggest the usage of these drugs for all overweight Americans.

Michaels said, “So if a person is very far down the road on that continuum, if they have chronic kidney disease, if they have heart disease, if they have advanced type 2 diabetes, if they’ve tried everything, if they’re morbidly obese, then obviously in the cost-benefit analysis they would be the appropriate candidate for these drugs and they could be considered a first line of defense. However, that’s not what we’re talking about. We’re talking about utilizing this drug as a first line of defense for human beings as young as six years old. We’re talking about a vast swath of the population, up to 28 million people that they would like to prescribe these drugs to that are simply not candidates.”

The NIH says weight loss medication can be prescribed to individuals with obesity or people who are overweight and have weight-related health problems, including high blood pressure and diabetes. The agency also states, “Weight management medications aren’t for everyone with a high BMI. If you are overweight or have obesity, you might be able to lose weight with a lifestyle program that changes your behaviors and improves your eating and physical activity habits.”

 

 

 

 

 

 

 

 

 

 

Steven Middendorp

Steven Middendorp is an investigative journalist, musician, and teacher. He has been a freelance writer and journalist for over 20 years. More recently, he has focused on issues dealing with corruption and negligence in the judicial system. He is a homesteading hobby farmer who encourages people to grow their own food, eat locally, and care for the land that provides sustenance to the community.

Other Headlines

Coronavirus

Yale Study Finds Post-Vaccine Syndrome Shares Symptoms with Long COVID

A preprint study from Yale University researchers examined a condition known as post-vaccination syndrome. The study included 42 individuals with PVS and 22 without. Researchers observed elevated levels of spike proteins in the PVS group for 36 to 709 days because the time that lapsed since the last vaccination varied between participants. It is aContinue reading Yale Study Finds Post-Vaccine Syndrome Shares Symptoms with Long COVID

More news about Coronavirus

Health & Nutrition

Jury Slams Bayer With Nearly $2.1B Verdict Over Glyphosate Cancer Claims

A Georgia jury has ruled against Bayer in which a plaintiff claimed his use of Roundup caused his non-Hodgkin’s Lymphoma. The nearly $2.1 billion verdict is the largest payout the biotechnology company has paid out, as 60,000 lawsuits are still pending. The verdict includes $65 million in compensatory damages and $2 billion in punitive damages.Continue reading Jury Slams Bayer With Nearly $2.1B Verdict Over Glyphosate Cancer Claims

More news about Health & Nutrition

Vaccines

RFK Jr. Halts COVID-19 Oral Vaccine Trial for 90 Days, Ends Flu Vaccine Ad Campaign

HHS Secretary Robert F. Kennedy Jr. paused a clinical trial funded by the Biomedical Advanced Research and Development Authority (BARDA) for a COVID-19 oral vaccine made by Vaxart. Kennedy said, “While it is crucial that the Department [of] Health and Human Services (HHS) support pandemic preparedness, four years of the Biden administration’s failed oversight haveContinue reading RFK Jr. Halts COVID-19 Oral Vaccine Trial for 90 Days, Ends Flu Vaccine Ad Campaign

More news about Vaccines

Science & Tech

23andMe Files for Chapter 11 Bankruptcy; Genetic Data of 15 Million Users at Risk of Sale

The genetic data of 15 million people will soon be for sale as 23andMe has filed for Chapter 11 bankruptcy. The attorneys general for California and New York issued consumer alerts to advise consumers to take action to protect their data. New York AG Rob Bonta said “There’s health insurance companies that are interested inContinue reading 23andMe Files for Chapter 11 Bankruptcy; Genetic Data of 15 Million Users at Risk of Sale

More news about Science & Tech

Environment

Bayer Seeks Capital Raise to Cover Roundup Lawsuit Settlements

Bayer continues to face struggles related to its acquisition of Monsanto and the flagship product Roundup, which currently has 67,000 pending cases alleging the herbicide has caused serious health conditions. So far, Bayer has paid out $10 billion to settle cases and has $5.9 billion set aside to resolve the pending cases. Sources told ReutersContinue reading Bayer Seeks Capital Raise to Cover Roundup Lawsuit Settlements

More news about Environment

Policy

Peter Marks Resigns From FDA As HHS Fires 10,000 Employees In Reorganization Effort

Dr. Peter Marks, an FDA official involved in Operation Warp Speed, has resigned from his position as director of the Center for Biologics Evaluation and Research (CBER). Marks started his career at the FDA as deputy director of the CBER in 2012 and has been the director since 2016. CBER is tasked with ensuring biologicalContinue reading Peter Marks Resigns From FDA As HHS Fires 10,000 Employees In Reorganization Effort

More news about Policy